ED
48
3
AMP
69
-3
L
62
2
GOOGL
54
-2
TGT
25
-24
QRVO
6
2
PRU
57
-3
NWL
44
-4
DTE
50
3
DHR
35
3
JPM
63
-4
MAS
51
4
IFF
53
2
PSA
51
-4
F
43
-8
SCHW
64
2
PDCO
35
-3
WDC
41
-2
DVA
72
2
URBN
38
-4
ED
48
3
AMP
69
-3
L
62
2
GOOGL
54
-2
TGT
25
-24
QRVO
6
2
PRU
57
-3
NWL
44
-4
DTE
50
3
DHR
35
3
JPM
63
-4
MAS
51
4
IFF
53
2
PSA
51
-4
F
43
-8
SCHW
64
2
PDCO
35
-3
WDC
41
-2
DVA
72
2
URBN
38
-4
Financhill
Back

ClearPoint Neuro 10K Form

Sell
22

CLPT
ClearPoint Neuro

Last Price:
11.10
Seasonality Move:
21.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLPT News And Ratings

See the #1 stock for the next 7 days that we like better than CLPT

CLPT Financial Statistics

Sales & Book Value

Annual Sales: $23.96M
Cash Flow: $-1.21M
Price / Cash Flow: 0
Annual Sales: $1.05
Price / Book: 10.22

Profitability

EPS (TTM): -0.69000
Net Income (TTM): $-18.15M
Gross Margin: $13.61M
Return on Equity: -64.36%
Return on Assets: -38.96%

ClearPoint Neuro Earnings Forecast

Key ClearPoint Neuro Financial Ratios

  • The Gross Profit Margin over the past 14 years for CLPT is 56.83%.
  • The Selling, General & Administrative Expenses for CLPT have been equal to 101.65% of Gross Profit Margin.
  • The Research & Development expenses have been 48.88% of Revenue.
  • The Interest Expense is -0.49% of Operating Income.
  • The Net Earning history of CLPT is -92.21% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 9 years.

ClearPoint Neuro Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: CLPT
CUSIP: 18507C
Website: clearpointneuro.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.54
Quick Ratio: 3.37

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLPT Technical Analysis vs Fundamental Analysis

Sell
22
ClearPoint Neuro (CLPT) is a Sell

Is ClearPoint Neuro a Buy or a Sell?

  • ClearPoint Neuro stock is rated a Sell
    The current ClearPoint Neuro [CLPT] share price is $10.96. The Score for CLPT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.